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Book Reviews
Behavioral Endocrinology. By Jill B.
Becker, S. MarcBreedlove, David Crews,
and Margaret M. McCarthy. Cambridge,
Massachusetts: MIT Press, 2002. 806 pp.
$50.00.
It is a rare thing to find a text written
as clearly, as accurately, and that is as
engaging as this! Although designed to
provide a basic understanding ofthe field
ofbehavioral endocrinology forthe college
and university-level student, there is much
inthis volumethat will be ofinterest to the
seasonedresearcher. Put simply, behavioral
endocrinologyisthe studyofhowhormones
influence ananimal'sbehavior; however, it
isnotasimpletopic atalland, inthe wrong
hands, hasthe potential to be not only con-
fusingbutalsotedious. Thisbookis neither
confusing nortedious. Theauthorswill, from
time to time, warn the reader that specific
sections of information contained in the
bookmaybe "denselypacked" -andthey
are. However, this does not happen fre-
quently, and when it does, it facilitates the
progression ofthe material covered. What
I found quite extraordinary about the book
is the way the authors made an effort to
engage the reader as to why a particular
issue in behavioral endocrinology is
important. (They have not assumed that all
readers or students who use their book
have plans to become behavioral endocri-
nologists.) They link their topics to con-
temporary social and cultural issues such
as drug doping within the athletic commu-
nity, methods to enhance orcontrol fertility,
and ways to enhance human memory and
cognitive performance.
From topics such as "Molecular
Approaches to Behavioral Neuroendo-
crinology" to "Hormones and Cognition in
Non-humanAnimals," the authorsconsistent-
lyengageandchallengethereaderinorderto
facilitate anunderstanding ofboththemate-
rial and the potential implications of this
information in ourworld.Aterrific volume.
C.A. Morgan, III
Associate Professor
Yale University School ofMedicine
What Evolution Is. By Ernst Mayr.
New York: Basic Books, 2002. 192 pp.
$26.00.
Few people, living or dead, can be
said to have had a greater impact on the
field of evolutionary biology than Ernst
Mayr, and any student of biology would
approach the confidently-titled essay What
EvolutionIs withhighexpectations. Unfor-
tunately, Mayr's goal ofwriting to bothbiol-
ogists and educated laypersons results in a
work that is too compact andjargon-laden
for most educated non-scientists and lacks
the depth and exploration of controversy
needed to appeal to professional scientists.
Although What Evolution Is contains pas-
sages ofgreatclarityand insight, pooredit-
ing and the superficialtreatment ofaspects
of its epic scope drag down what could
have been an invaluable and entertaining
finale to an accomplished authorial career.
The coarse-grained organization of
WhatEvolutionIs is appealing and logical:
a description ofthe Earth's natural history
andthe evidence that represents the pattern
ofevolution leads into a discussion ofthe
processes that cause change in populations.
These mechanisms are then used as the
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basis for exploring the macroevolutionary
history of Earth and the origin ofspecies.
Finally, all these elements are nicely syn-
thesized in a particularly readable chapter
on human evolution and both our unique-
ness from and our similarity to other
species.Abriefrecap ofsomemajorareas of
active research precedes two appendices,
one ofwhich adopts the "frequently asked
questions" modelto provide auseful primer
to those readers still confused on primary
points ofthe text.
Editing problems are evident from the
beginning,andtheirfrequencythroughoutthe
book is easily the most frustrating andpre-
ventable flaw in hatEvolutionIs. Entirely
redundant sentences and even paragraphs
are littered throughout most sections, exacer-
batingtheconfusionproducedbythealready
confusing organization ofmany chapters.
Mayr's ambitious attempts to coverall
aspects of evolution create a more under-
standable problem. While zoologists may
enjoyreading atextwith abias toward ani-
mals,those interested inotherkingdomswill
be fiustratedbythe superficial treatment of
the evolution ofplants andmicrobes. What
statements do address these topics are often
imprecise and written with an uncertainty
that sharply contrasts Mayr's confident
descriptions ofmost topics. Ofcourse, this
only proves the difficulty of any one per-
son, regardless of their experience in the
field, writing with equal knowledge and
confidence on all aspects ofa mature sci-
ence, but a book with such an ambitious
title puts exactlythis burden on the author.
Although Mayr lists creationists and evo-
lutionary agnostics as target audiences of
this essay, I doubt many members ofeither
group will find themselves convinced by
the presentation of evidence here. Mayr
himselfis so convinced ofevolution, andso
steeped inthe evidence forit, thathe seems
unable orunwillingtoaddress itsacceptance
from the position ofan outsider. Although
Mayr's logical presentation ofevidence is
at all times sound and well-reasoned, his
seemingly compulsive use of jargon and
extreme confidence may lead many read-
ers outside ofbiology to dismiss this work
as dogmatism. Non-scientists accustomed
to the plurality ofviewpoints contrasted in
works ofscientific journalism, or the con-
troversial speculation and philosophy of
manypopular science books, may find little
to holdtheirattention inthe first few chap-
ters ofthis work, which follow more ofa
textbook style. Biologists will find much
ofinterest here, but anyone with a serious
interest in evolution as a scientific enter-
prise would find the comprehensiveness of
a textbook or a few reviews plucked from
the primary literature more to their liking.
Jeremy Draghi
Yale University
Vector Targeting for Therapeutic
Gene Delivery. Edited by David T.
Curiel and JoanneT. Douglas. Hoboken,
New Jersey: John Wiley & Sons, 2002.
664 pp. $135.00.
Since the first tentative and faltering
steps were taken inthe late 1970s andearly
1980s, attempts to bring successful gene
therapy treatments to humans have been rid-
dled with failure. The past few years have
beenparticularlydisappointing forthis field.
In 1999, the death of a young man in a
clinicaltrialusingadenovirustotreat aliver
disease brought abarrage ofnegative pub-
licity and impacted the progress of many
other trials underway. Most recently, the
only successful treatment, using retrovirus
vectors to treat SCID (severe combined
immunodeficiency) sufferedamajorsetback
when it was discovered that two patients
had contracted leukemia. These and other
setbacks have causedresearchers to rethink
some of the strategies used in designing
vectors. In VectorTargetingfor Therapeutic
Gene Delivery, the editors, DavidT. Curiel
and Joanne T. Douglas have sought to
compile a book dedicated to gene therapy
research that focuses on vector targeting.
The editors point out that many ofthe lim-